Notice2022-18441
Agency Forms Undergoing Paperwork Reduction Act Review
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 26, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 165 (Friday, August 26, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 165 (Friday, August 26, 2022)]
[Notices]
[Pages 52579-52580]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-18441]
[[Page 52579]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-22-0009]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Disease Surveillance Program--I.
Case Reports'' to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on May 23,
2022, to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Disease Surveillance Program--I. Case Reports (OMB Control
No. 0920-0009, Exp. 08/31/2022)--Revision--National Center for Emerging
and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Surveillance of the incidence and distribution of disease has been
an important function of the US Public Health Service (PHS) since an
1878 Act of Congress authorized the PHS to collect morbidity reports.
After the Malaria Control in War Areas Program had fulfilled its
original 1942 objective of reducing malaria transmission, its basic
tenets were carried forward and broadened by the formation of the
Communicable Disease Center (CDC) in 1946. CDC was conceived of as a
well-equipped, broadly staffed agency used to translate facts about
analysis of morbidity and mortality statistics on communicable diseases
and through field investigations. It was soon recognized that control
measures (such as the DDT spraying for malaria) did not alleviate the
threat of disease reintroduction. In 1950, the Malaria Surveillance
Program began and in 1952, the National Surveillance Program started.
Both programs were based on the premise that diseases cannot be
diagnosed, prevented, or controlled until existing knowledge is
expanded and new ideas developed and implemented. The original scope of
the National Surveillance Program included the study of malaria, murine
typhus, smallpox, psittacosis, diphtheria, leprosy, and sylvatic
plague. Over the years, the mandate of CDC has broadened in preventive
health activities and the surveillance systems maintained have
expanded. This program is authorized under the Public Health Service
Act, Section 301 and 306 (42 U.S.C. 241 and 242K).
This ICR covers surveillance activities for four, rare diseases:
1. Creutzfeldt-Jakob Disease (CJD)
2. Reye Syndrome
3. Kawasaki Syndrome
4. Acute Flaccid Myelitis
CDC requests OMB approval for an estimated 98 annual burden hours.
There is no cost to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Epidemiologist........................ Creutzfeldt-Jakob 10 2 20/60
Disease (CJD).
Reye Syndrome........... 1 1 20/60
Kawasaki Syndrome....... 20 2 15/60
Acute Flaccid Myelitis.. 100 4 12/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-18441 Filed 8-25-22; 8:45 am]
BILLING CODE 4163-18-P
</pre></body>
</html>Indexed from Federal Register on August 26, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.